Phase 3 Open-Label Study Evaluating the Efficacy and Safety of Mavacamten in Japanese Adults With Obstructive Hypertrophic Cardiomyopathy ― The HORIZON-HCM Study ―Hiroaki Kitaoka, Chisato Izumi, Ken Kozuma et al.|Circulation Journal|2024Cited by 23
Validation of the 2018 Japanese Circulation Society (JCS)/Japanese Heart Failure Society (JHFS) Guidelines for Preventing Sudden Cardiac Death in Patients With Hypertrophic CardiomyopathyMasashi Amano, Hiroaki Kitaoka, Yusuke Yoshikawa et al.|Circulation Journal|2025Cited by 1